Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05432089Phase 2Recruiting
A Phase 2 trial of oxytocin nasal spray in severe mental illness (SMI), sponsored by Shalvata Mental Health Center. Started Mar 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05432089.